Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23 Pharmaceutical Investing
Avricore Health Corporate Update - Earnings Advisory 2022 and 2023 Objectives Pharmaceutical Investing
Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits Pharmaceutical Investing
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy Pharmaceutical Investing
Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation Medical Device Investing
Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook Pharmaceutical Investing
Viemed Wins Complete Overruling of Appealed OIG Claims Resolving Multiyear Process With HHS and CMS Medical Device Investing
Osteopore to Acquire Multiple Medical Distribution Businesses & Become Vertically Integrated Medical Device Investing
